WO2007003344A3 - Device for quantitative analysis of a metabolite profile - Google Patents
Device for quantitative analysis of a metabolite profile Download PDFInfo
- Publication number
- WO2007003344A3 WO2007003344A3 PCT/EP2006/006328 EP2006006328W WO2007003344A3 WO 2007003344 A3 WO2007003344 A3 WO 2007003344A3 EP 2006006328 W EP2006006328 W EP 2006006328W WO 2007003344 A3 WO2007003344 A3 WO 2007003344A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- quantitative analysis
- metabolite profile
- relates
- present
- drug
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00594—Quality control, including calibration or testing of components of the analyser
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/30—Data warehousing; Computing architectures
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/0027—Methods for using particle spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
Abstract
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0613478A BRPI0613478B8 (en) | 2005-06-30 | 2006-06-29 | device for quantitative analysis of a metabolite profile |
CN200680022942A CN100594501C (en) | 2005-06-30 | 2006-06-29 | Device for quantitative analysis of a metabolite profile |
AU2006265381A AU2006265381B2 (en) | 2005-06-30 | 2006-06-29 | Device for quantitative analysis of a metabolite profile |
IN2241DEN2014 IN2014DN02241A (en) | 2005-06-30 | 2006-06-29 | |
JP2008518727A JP5155160B2 (en) | 2005-06-30 | 2006-06-29 | Equipment for quantitative analysis of metabolite characteristics |
DK06754632.5T DK1875401T3 (en) | 2005-06-30 | 2006-06-29 | Device for quantitative analysis of a metabolite profile |
EP06754632.5A EP1875401B1 (en) | 2005-06-30 | 2006-06-29 | Device for quantitative analysis of a metabolite profile |
NZ563431A NZ563431A (en) | 2005-06-30 | 2006-06-29 | Device for quantitative analysis of a metabolite profile |
CA2608965A CA2608965C (en) | 2005-06-30 | 2006-06-29 | Device for quantitative analysis of a metabolite profile |
IL187470A IL187470A (en) | 2005-06-30 | 2007-11-19 | Device for quantitative analysis of a metabolite profile |
NO20080559A NO339319B1 (en) | 2005-06-30 | 2008-01-30 | Device for quantitative analysis of a metabolite profile |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69498305P | 2005-06-30 | 2005-06-30 | |
US69498405P | 2005-06-30 | 2005-06-30 | |
US60/694,983 | 2005-06-30 | ||
US60/694,984 | 2005-06-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007003344A2 WO2007003344A2 (en) | 2007-01-11 |
WO2007003344A3 true WO2007003344A3 (en) | 2007-04-26 |
Family
ID=36783737
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/006328 WO2007003344A2 (en) | 2005-06-30 | 2006-06-29 | Device for quantitative analysis of a metabolite profile |
PCT/EP2006/006327 WO2007003343A1 (en) | 2005-06-30 | 2006-06-29 | Apparatus and method for analyzing a metabolite profile |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/006327 WO2007003343A1 (en) | 2005-06-30 | 2006-06-29 | Apparatus and method for analyzing a metabolite profile |
Country Status (16)
Country | Link |
---|---|
US (2) | US8265877B2 (en) |
EP (2) | EP1897014B1 (en) |
JP (2) | JP4829297B2 (en) |
KR (1) | KR100967573B1 (en) |
CN (1) | CN100594501C (en) |
AU (1) | AU2006265381B2 (en) |
BR (1) | BRPI0613478B8 (en) |
CA (2) | CA2608963C (en) |
DK (2) | DK1897014T3 (en) |
ES (1) | ES2452025T3 (en) |
IL (1) | IL187470A (en) |
IN (1) | IN2014DN02241A (en) |
NO (1) | NO339319B1 (en) |
NZ (1) | NZ563431A (en) |
RU (1) | RU2391672C2 (en) |
WO (2) | WO2007003344A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7169278B2 (en) | 2017-01-18 | 2022-11-10 | バイオクラテス ライフ サイエンシズ アクチェンゲゼルシャフト | A novel biomarker for evaluating ovarian cancer |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2585395A (en) | 1994-05-09 | 1995-11-29 | Chiron Corporation | Retroviral vectors having a reduced recombination rate |
US8969089B2 (en) | 2004-10-12 | 2015-03-03 | Quest Diagnostics Investments, Inc. | Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry |
WO2007003344A2 (en) * | 2005-06-30 | 2007-01-11 | Biocrates Life Sciences Ag | Device for quantitative analysis of a metabolite profile |
AU2007248476B2 (en) * | 2006-05-05 | 2012-09-06 | Perkinelmer Las, Inc | Quantitative analysis of surface-derived samples using mass spectrometry |
EP1923806A1 (en) * | 2006-11-14 | 2008-05-21 | Metanomics GmbH | Fast metabolomic analysis and system therefor |
US7999084B2 (en) * | 2007-05-16 | 2011-08-16 | Agilent Technologies, Inc. | Devices and methods for reducing matrix effects |
WO2008145385A1 (en) * | 2007-05-31 | 2008-12-04 | Biocrates Life Sciences Ag | Biomarker and method for determining an oxidative stress level |
JP2010528302A (en) * | 2007-05-31 | 2010-08-19 | バイオクレイツ ライフ サイエンス エージー | Inflammation and oxidative stress level assay |
CN101796408B (en) * | 2007-06-29 | 2014-05-07 | 奎斯特诊断投资公司 | Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry |
JP5306345B2 (en) * | 2007-07-26 | 2013-10-02 | フェノメノーム ディスカバリーズ インク | Methods for diagnosing, assessing risk and monitoring autism spectrum disorders |
DE102007043614B3 (en) * | 2007-09-13 | 2008-11-20 | Biocrates Life Sciences Gmbh | Retainer for wells of multi-corrugated plate, has support arranged in opening below retaining bar, where retainer rests with lateral outer surfaces of support bars, retaining bar and/or connecting rods against inner side of opening |
WO2009043149A1 (en) * | 2007-10-01 | 2009-04-09 | Mds Analytical Technologies, A Business Unit Of Mds Inc., Doing Business Through Its Sciex Division | Analysis of conjugated metabolites of alcohol consumption |
WO2009070233A1 (en) * | 2007-11-26 | 2009-06-04 | Waters Technologies Corporation | Internal standards and methods for use in quantitatively measuring analytes in a sample |
US9983099B2 (en) * | 2008-06-13 | 2018-05-29 | Smiths Detection Montreal Inc. | Analytical instrument with temporal control of ion mobility spectrometer control parameters |
CA2743211A1 (en) | 2008-11-12 | 2010-05-20 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Methods and systems of using exosomes for determining phenotypes |
EP2192196A1 (en) | 2008-11-27 | 2010-06-02 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Prediction of lipid-metabotype-related physiological susceptibilities |
CN102326073B (en) | 2009-03-05 | 2013-11-13 | 株式会社日立高新技术 | Analysis apparatus |
CN102414778B (en) * | 2009-04-30 | 2016-03-16 | 普度研究基金会 | Moist porous material is used to produce ion |
US9500572B2 (en) | 2009-04-30 | 2016-11-22 | Purdue Research Foundation | Sample dispenser including an internal standard and methods of use thereof |
EP2249161B1 (en) | 2009-05-05 | 2020-05-13 | InfanDx AG | Method of diagnosing asphyxia |
US20120129265A1 (en) * | 2009-06-02 | 2012-05-24 | Biocrates Life Sciences Ag | New biomarkers for assessing kidney diseases |
WO2011066589A1 (en) | 2009-11-30 | 2011-06-03 | Caris Life Sciences Luxembourg Holdings | Methods and systems for isolating, storing, and analyzing vesicles |
CA2787027A1 (en) | 2010-01-13 | 2011-07-21 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Detection of gastrointestinal disorders |
US9128101B2 (en) | 2010-03-01 | 2015-09-08 | Caris Life Sciences Switzerland Holdings Gmbh | Biomarkers for theranostics |
JP2013526852A (en) | 2010-04-06 | 2013-06-27 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス | Circulating biomarkers for disease |
JP5894078B2 (en) | 2010-10-29 | 2016-03-23 | アトナープ株式会社 | Sampling device |
SG190070A1 (en) | 2010-10-29 | 2013-06-28 | Thermo Fisher Scientific Oy | System layout for an automated system for sample preparation and analysis |
EP2492690A1 (en) * | 2011-02-22 | 2012-08-29 | BIOCRATES Life Sciences AG | Method and use of metabolites for the diagnosis of inflammatory brain injury in preterm born infants |
EP2587264A1 (en) | 2011-10-25 | 2013-05-01 | InfanDx AG | Method and use of metabolites for the diagnosis and differentiation of neonatal encephalopathy |
JP6444736B2 (en) | 2011-11-23 | 2018-12-26 | クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド | Detection of kisspeptin-54 by tandem mass spectrometry |
JP6198408B2 (en) * | 2012-04-02 | 2017-09-20 | 株式会社日立ハイテクノロジーズ | Method for analyzing volatile substances in sample liquid |
US8870028B2 (en) | 2012-05-25 | 2014-10-28 | Restek Corporation | Dispensing device |
CN104769434B (en) * | 2012-08-13 | 2018-01-02 | 亥姆霍兹慕尼黑中心德国研究健康与环境有限责任公司 | Biomarker for diabetes B |
WO2014072537A1 (en) | 2012-11-12 | 2014-05-15 | Biocrates Life Sciences Ag | Use of quality indicators for checking thawing processes in frozen sample tissues |
WO2014110196A1 (en) * | 2013-01-10 | 2014-07-17 | Restek Corporation | Dispensing device and method |
BR112015018484A2 (en) | 2013-01-31 | 2017-07-18 | Purdue Research Foundation | methods of analyzing crude oil |
US10008375B2 (en) | 2013-01-31 | 2018-06-26 | Purdue Research Foundation | Systems and methods for analyzing an extracted sample |
WO2014209474A1 (en) | 2013-06-25 | 2014-12-31 | Purdue Research Foundation | Mass spectrometry analysis of microorganisms in samples |
CN103558354B (en) | 2013-11-15 | 2015-07-15 | 南京大学 | Water toxicity analysis method based on biologic omics integrated technology |
JP2017101924A (en) * | 2014-03-31 | 2017-06-08 | 積水メディカル株式会社 | Internal standard substance reagent |
CN104200087B (en) * | 2014-06-05 | 2018-10-02 | 清华大学 | For the parameter optimization of machine learning and the method and system of feature tuning |
US9786478B2 (en) | 2014-12-05 | 2017-10-10 | Purdue Research Foundation | Zero voltage mass spectrometry probes and systems |
CN107960130A (en) | 2015-02-06 | 2018-04-24 | 普度研究基金会 | Probe, system, box and its application method |
EP3171173A1 (en) | 2015-11-19 | 2017-05-24 | Medizinische Universität Innsbruck | Method of diagnosis of a thoracic aortic aneurysm |
US10001501B2 (en) | 2015-12-31 | 2018-06-19 | Universal Diagnostics, S. L. | Systems and methods for automated, customizable sample preparation for detection of metabolites and lipids |
DE102017112612A1 (en) * | 2016-06-10 | 2017-12-14 | Hitachi High-Tech Science Corporation | A liquid chromatograph and method for correcting variations in a detector output of the liquid chromatograph |
US10607723B2 (en) | 2016-07-05 | 2020-03-31 | University Of Kentucky Research Foundation | Method and system for identification of metabolites using mass spectra |
EP3535418B1 (en) * | 2016-11-07 | 2021-12-15 | Battelle Memorial Institute | Nanoscale biochemical sample preparation and analysis |
US11719702B2 (en) * | 2016-11-07 | 2023-08-08 | Battelle Memorial Institute | Methods and systems of proteome analysis and imaging |
EP3376230A1 (en) | 2017-03-13 | 2018-09-19 | Biocross, S.L. | Identification of signatures for neurodegeneration diseases diagnoses |
WO2018174876A1 (en) * | 2017-03-22 | 2018-09-27 | Mprobe Inc. | Methods and compositions for providing a preeclampsia assessment with metabolites |
CN107727850B (en) * | 2017-10-10 | 2021-08-27 | 常州博闻迪医药股份有限公司 | Lateral flow chromatography detection reaction start control method |
EP3624691A1 (en) * | 2017-05-17 | 2020-03-25 | Radiometer Medical ApS | Porous optical fiber for the detection of an analyte in a fluid |
CN107561150A (en) * | 2017-07-03 | 2018-01-09 | 宁波华仪宁创智能科技有限公司 | The detection method of drug abuse |
CN107798981A (en) * | 2017-10-31 | 2018-03-13 | 楚雄医药高等专科学校 | A kind of permanent teaching micro-capsule sample slice and preparation method thereof |
CN109030673A (en) * | 2018-07-04 | 2018-12-18 | 易达精准(杭州)科技有限公司 | The detection method and detection kit of immunosuppressor in dried blood spot |
CN109298115B (en) * | 2018-10-19 | 2020-07-28 | 深圳市绘云生物科技有限公司 | Quantitative detection method for multiple metabolites in biological sample and metabolic chip |
WO2020099683A1 (en) | 2018-11-16 | 2020-05-22 | Biocrates Life Sciences Ag | Metabolites for use in ovarian cancer detection and diagnosis |
FR3091351B1 (en) | 2018-12-27 | 2021-05-21 | Univ Rouen Centre Hospitalier | FABRY'S DISEASE BIOMARKER |
KR102035162B1 (en) * | 2019-03-12 | 2019-11-08 | 한국과학기술원 | Method for predicting drug candidate for diseases by using human metabolite specific for the disease target metabolizing enzyme |
CN111579665B (en) | 2020-05-20 | 2021-11-05 | 苏州帕诺米克生物医药科技有限公司 | UPLC/HRMS-based metabonomics relative quantitative analysis method |
WO2021237035A1 (en) * | 2020-05-21 | 2021-11-25 | Mayo Foundation For Medical Education And Research | Calibration methods for mass spectrometry measurements |
CN111704654B (en) * | 2020-06-18 | 2021-12-03 | 上海交通大学医学院附属仁济医院 | Peptide compound and preparation method and application thereof |
US11754536B2 (en) | 2021-11-01 | 2023-09-12 | Matterworks Inc | Methods and compositions for analyte quantification |
JP7206365B1 (en) | 2021-12-22 | 2023-01-17 | 浜松ホトニクス株式会社 | sample support |
KR102547430B1 (en) * | 2022-11-16 | 2023-06-23 | (주)애터미오롯 | Method for qualitative analysis of noni-containing composition |
CN117538530A (en) * | 2023-11-07 | 2024-02-09 | 中国医学科学院肿瘤医院 | Biomarker composition and kit for detecting metastatic breast cancer and application of biomarker composition and kit |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996024062A1 (en) * | 1995-02-01 | 1996-08-08 | Cornell Research Foundation, Inc. | Liposome-enhanced immunoaggregation assay and test device |
WO2000072019A2 (en) * | 1999-05-20 | 2000-11-30 | Cornell Research Foundation, Inc. | Liposome-enhanced test device and method |
WO2003016861A2 (en) * | 2001-08-14 | 2003-02-27 | President And Fellows Of Harvard College | Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry |
US20030044799A1 (en) * | 2001-08-31 | 2003-03-06 | Matson Robert S. | Analysis using a distributed sample |
GB2385918A (en) * | 2001-12-08 | 2003-09-03 | Micromass Ltd | Method of mass spectrometry |
WO2005031304A2 (en) * | 2003-09-22 | 2005-04-07 | Becton, Dickinson And Company | Quantification of analytes using internal standards |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9718129D0 (en) * | 1997-08-27 | 1997-10-29 | Isis Innovation | Branched structures |
US6258605B1 (en) * | 1999-03-26 | 2001-07-10 | Neo Gen Screening, Inc. | Clinical method for the genetic screening of newborns using tandem mass spectrometry |
US6455321B1 (en) * | 1999-01-30 | 2002-09-24 | Neo Gen Screening, Inc. | Method for interpreting tandem mass spectrometry data for clinical diagnosis |
US20020009394A1 (en) * | 1999-04-02 | 2002-01-24 | Hubert Koster | Automated process line |
EP1113269B1 (en) * | 1999-12-29 | 2006-10-18 | PerkinElmer Life Sciences, Inc. | Test tray, kit and methods for screening body fluids of newborns by tandem mass spectrometry |
AU2001262943A1 (en) * | 2000-04-14 | 2001-10-30 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
US6680203B2 (en) | 2000-07-10 | 2004-01-20 | Esperion Therapeutics, Inc. | Fourier transform mass spectrometry of complex biological samples |
CA2416744A1 (en) * | 2000-07-18 | 2002-01-24 | Invitrogen Corporation | Device and methods for subdividing and filtering gel material and extracting molecules therefrom |
US6627444B1 (en) * | 2000-08-07 | 2003-09-30 | Smiths Detection - Toronto Ltd. | Method and solid phase calibration sample for calibration of analytical instructions |
US20020155587A1 (en) | 2001-04-20 | 2002-10-24 | Sequenom, Inc. | System and method for testing a biological sample |
AU2002320316A1 (en) | 2001-07-06 | 2003-01-21 | Lipomics Technologies, Inc. | Generating, viewing, interpreting, and utilizing a quantitative database of metabolites |
US6939716B2 (en) | 2001-09-19 | 2005-09-06 | Washington University | Method for detecting conditions indicative of sepsis |
US20030129760A1 (en) * | 2001-11-13 | 2003-07-10 | Aguilera Frank Reinaldo Morales | Mass intensity profiling system and uses thereof |
US20040023295A1 (en) * | 2001-11-21 | 2004-02-05 | Carol Hamilton | Methods and systems for analyzing complex biological systems |
GB0128498D0 (en) | 2001-11-28 | 2002-01-23 | Inst Of Child Health | International standards for sphingolipids |
AUPS177202A0 (en) * | 2002-04-16 | 2002-05-23 | Diakyne Pty Ltd | Multi-element screening of trace elements |
WO2004038602A1 (en) | 2002-10-24 | 2004-05-06 | Warner-Lambert Company, Llc | Integrated spectral data processing, data mining, and modeling system for use in diverse screening and biomarker discovery applications |
AU2003286726A1 (en) | 2002-10-25 | 2004-05-13 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
EP1556684A4 (en) * | 2002-11-01 | 2008-01-23 | Univ Colorado Regents | Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry |
US20040121305A1 (en) | 2002-12-18 | 2004-06-24 | Wiegand Roger Charles | Generation of efficacy, toxicity and disease signatures and methods of use thereof |
US6909981B2 (en) * | 2003-01-27 | 2005-06-21 | Ciphergen Biosystems, Inc. | Data management system and method for processing signals from sample spots |
US7964343B2 (en) | 2003-05-13 | 2011-06-21 | Ibis Biosciences, Inc. | Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
KR20050050714A (en) * | 2003-11-26 | 2005-06-01 | 매그나칩 반도체 유한회사 | Method for fabricating transistor of semiconductor device |
US7745226B2 (en) * | 2005-04-06 | 2010-06-29 | Quest Diagnostics Investments Incorporated | Methods for detecting vitamin D metabolites |
WO2007003344A2 (en) * | 2005-06-30 | 2007-01-11 | Biocrates Life Sciences Ag | Device for quantitative analysis of a metabolite profile |
-
2006
- 2006-06-29 WO PCT/EP2006/006328 patent/WO2007003344A2/en active Application Filing
- 2006-06-29 JP JP2008518726A patent/JP4829297B2/en active Active
- 2006-06-29 CN CN200680022942A patent/CN100594501C/en active Active
- 2006-06-29 JP JP2008518727A patent/JP5155160B2/en active Active
- 2006-06-29 RU RU2008102835/14A patent/RU2391672C2/en active
- 2006-06-29 EP EP06754631.7A patent/EP1897014B1/en active Active
- 2006-06-29 ES ES06754631.7T patent/ES2452025T3/en active Active
- 2006-06-29 CA CA2608963A patent/CA2608963C/en active Active
- 2006-06-29 EP EP06754632.5A patent/EP1875401B1/en active Active
- 2006-06-29 BR BRPI0613478A patent/BRPI0613478B8/en active IP Right Grant
- 2006-06-29 NZ NZ563431A patent/NZ563431A/en unknown
- 2006-06-29 KR KR1020077030772A patent/KR100967573B1/en active IP Right Grant
- 2006-06-29 DK DK06754631.7T patent/DK1897014T3/en active
- 2006-06-29 IN IN2241DEN2014 patent/IN2014DN02241A/en unknown
- 2006-06-29 WO PCT/EP2006/006327 patent/WO2007003343A1/en not_active Application Discontinuation
- 2006-06-29 US US11/476,637 patent/US8265877B2/en active Active
- 2006-06-29 DK DK06754632.5T patent/DK1875401T3/en active
- 2006-06-29 AU AU2006265381A patent/AU2006265381B2/en active Active
- 2006-06-29 CA CA2608965A patent/CA2608965C/en active Active
- 2006-06-29 US US11/476,657 patent/US8116983B2/en active Active
-
2007
- 2007-11-19 IL IL187470A patent/IL187470A/en active IP Right Grant
-
2008
- 2008-01-30 NO NO20080559A patent/NO339319B1/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996024062A1 (en) * | 1995-02-01 | 1996-08-08 | Cornell Research Foundation, Inc. | Liposome-enhanced immunoaggregation assay and test device |
WO2000072019A2 (en) * | 1999-05-20 | 2000-11-30 | Cornell Research Foundation, Inc. | Liposome-enhanced test device and method |
WO2003016861A2 (en) * | 2001-08-14 | 2003-02-27 | President And Fellows Of Harvard College | Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry |
US20030044799A1 (en) * | 2001-08-31 | 2003-03-06 | Matson Robert S. | Analysis using a distributed sample |
GB2385918A (en) * | 2001-12-08 | 2003-09-03 | Micromass Ltd | Method of mass spectrometry |
WO2005031304A2 (en) * | 2003-09-22 | 2005-04-07 | Becton, Dickinson And Company | Quantification of analytes using internal standards |
US20050112635A1 (en) * | 2003-09-22 | 2005-05-26 | Becton, Dickinson And Company | Quantification of analytes using internal standards |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7169278B2 (en) | 2017-01-18 | 2022-11-10 | バイオクラテス ライフ サイエンシズ アクチェンゲゼルシャフト | A novel biomarker for evaluating ovarian cancer |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007003344A3 (en) | Device for quantitative analysis of a metabolite profile | |
WO2008039946A3 (en) | Integrated meter for analyzing biological samples | |
EP1966731A4 (en) | Method for ascertaining interferants in small liquid samples in an automated clinical analyzer | |
EP1867978A4 (en) | Method of analyte analysis and analyte analyzer | |
EP1819283A4 (en) | System and method for analyte sampling and analysis with hydrogel | |
EP1882950A4 (en) | Testing chip for analyzing target substance contained in analyte, and microscopic comprehensive analytical system | |
EP1849001A4 (en) | Lateral flow test kit and method for detecting an analyte | |
AU2013207599A1 (en) | Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof | |
EP1820021B8 (en) | Improved method of electrochemical analysis of an analyte | |
WO2005067582A3 (en) | Methods and apparatus for enhanced sample identification based on combined analytical techniques | |
WO2009134944A3 (en) | Methods of determining the health status of an individual | |
WO2008045526A3 (en) | Method and device for preparing an analyte for analysis by mass spectrometry | |
WO2009051821A3 (en) | Sample preparation devices and analyzers | |
EP1739402A4 (en) | Methods of separating, identifying and dispensing specimen and device therefor, and analyzing device method | |
GB2439032B (en) | Method and system for sample testing | |
EP1960112A4 (en) | Enrichment unit for biological components and an enrichment method | |
EP1672984A4 (en) | Methods for reducing the range in concentrations of analyte species in a sample | |
GB0507457D0 (en) | Improvements in or relating to methods and apparatus for analyzing biological samples by mass spectrometry | |
WO2010141075A8 (en) | Specific analysis of ketone and aldehyde analytes using reagent compounds, labeling strategies, and mass spectrometry workflow | |
EP1904653A4 (en) | Microfluidic methods and apparatuses for sample preparation and analysis | |
EP1939611A4 (en) | Method for detecting sample supply condition, and analyzer | |
EP1873522A4 (en) | Method for determination of hemoglobin derivative, and reagent composition, assay kit, analysis device and analysis system for use in the method | |
WO2009142835A3 (en) | Method and apparatus for analyzing skin and hair | |
WO2006132797A3 (en) | Preparation of small liquid samples for automated analysis | |
EP1930726A4 (en) | Method of assaying substance with affinity in sample including step of destroying blood-cell ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 563431 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2608965 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006754632 Country of ref document: EP Ref document number: 187470 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/016553 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 9888/DELNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200680022942.3 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008518727 Country of ref document: JP Ref document number: 1020077030772 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006265381 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006754632 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008102835 Country of ref document: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006265381 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006265381 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: PI0613478 Country of ref document: BR Kind code of ref document: A2 Effective date: 20071228 |